Add to ORKGEmergence of multidrug resistant influenza A(H1N1)pdm09 virus variants in an immunocompromised child treated with oseltamivir and zanamivir
Introduction A child with severe combined immunodeficiency (SCID) had an influenza A(H1N1)pdm09 infe...
The neuraminidase inhibitors zanamivir and oseltamivir are marketed for the treatment and prophylaxi...
Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral...
Prolonged treatment of an immunocompromised child with oseltamivir and zanamivir for A(H1N1)pdm09 vi...
Background: Oseltamivir is considered the drug of choice for patients with pandemic influenza for wh...
A three-year old immunocompromised child receiving oseltamivir for a 2009 pandemic influenza A virus...
Recent case reports describe multidrug-resistant influenza A pandemic (H1N1) 2009 virus infection in...
Recent case reports describe multidrug-resistant influenza A pandemic (H1N1) 2009 virus infection in...
Neuraminidase (NA) inhibitors (NAIs), including oseltamivir and zanamivir, play an important therape...
We describe the first confirmed person-to-person transmission of oseltamivir-resistant pandemic infl...
An influenza A(H1N1)pdm09 infection was diagnosed in a hematopoietic stem cell transplant recipient ...
During May 2009–April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in M...
The clinical use of the neuraminidase inhibitor (NAI) oseltamivir is associated with the emergence o...
Purpose: There was a global increase in the prevalence of oseltamivir-resistant influenza viruses du...
We report the emergence of an influenza virus A/H3N2-E119V neuraminidase variant from an elderly pat...
Introduction A child with severe combined immunodeficiency (SCID) had an influenza A(H1N1)pdm09 infe...
The neuraminidase inhibitors zanamivir and oseltamivir are marketed for the treatment and prophylaxi...
Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral...
Prolonged treatment of an immunocompromised child with oseltamivir and zanamivir for A(H1N1)pdm09 vi...
Background: Oseltamivir is considered the drug of choice for patients with pandemic influenza for wh...
A three-year old immunocompromised child receiving oseltamivir for a 2009 pandemic influenza A virus...
Recent case reports describe multidrug-resistant influenza A pandemic (H1N1) 2009 virus infection in...
Recent case reports describe multidrug-resistant influenza A pandemic (H1N1) 2009 virus infection in...
Neuraminidase (NA) inhibitors (NAIs), including oseltamivir and zanamivir, play an important therape...
We describe the first confirmed person-to-person transmission of oseltamivir-resistant pandemic infl...
An influenza A(H1N1)pdm09 infection was diagnosed in a hematopoietic stem cell transplant recipient ...
During May 2009–April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in M...
The clinical use of the neuraminidase inhibitor (NAI) oseltamivir is associated with the emergence o...
Purpose: There was a global increase in the prevalence of oseltamivir-resistant influenza viruses du...
We report the emergence of an influenza virus A/H3N2-E119V neuraminidase variant from an elderly pat...
Introduction A child with severe combined immunodeficiency (SCID) had an influenza A(H1N1)pdm09 infe...
The neuraminidase inhibitors zanamivir and oseltamivir are marketed for the treatment and prophylaxi...
Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral...